153 related articles for article (PubMed ID: 30923665)
21. Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3'-substituted tyrosine derivatives.
Song YL; Peach ML; Roller PP; Qiu S; Wang S; Long YQ
J Med Chem; 2006 Mar; 49(5):1585-96. PubMed ID: 16509576
[TBL] [Abstract][Full Text] [Related]
22. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
Lubman OY; Waksman G
J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
[TBL] [Abstract][Full Text] [Related]
23. Structural basis for a non-phosphorus-containing cyclic peptide binding to Grb2-SH2 domain with high affinity.
Li P; Zhang M; Peach ML; Zhang X; Liu H; Nicklaus M; Yang D; Roller PP
Biochem Biophys Res Commun; 2003 Aug; 307(4):1038-44. PubMed ID: 12878216
[TBL] [Abstract][Full Text] [Related]
24. Functional preference of the constituent amino acid residues in a phage-library-based nonphosphorylated inhibitor of the Grb2-SH2 domain.
Lung FD; Long YQ; Roller PP; King CR; Varady J; Wu XW; Wang S
J Pept Res; 2001 Jun; 57(6):447-54. PubMed ID: 11437948
[TBL] [Abstract][Full Text] [Related]
25. Nuclear magnetic resonance solution structure of the growth factor receptor-bound protein 2 Src homology 2 domain.
Thornton KH; Mueller WT; McConnell P; Zhu G; Saltiel AR; Thanabal V
Biochemistry; 1996 Sep; 35(36):11852-64. PubMed ID: 8794768
[TBL] [Abstract][Full Text] [Related]
26. The dynamics of free and phosphopeptide-bound Grb2-SH2 reveals two dynamically independent subdomains and an encounter complex with fuzzy interactions.
Sanches K; Caruso IP; Almeida FCL; Melo FA
Sci Rep; 2020 Aug; 10(1):13040. PubMed ID: 32747626
[TBL] [Abstract][Full Text] [Related]
27. Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands.
Rahuel J; García-Echeverría C; Furet P; Strauss A; Caravatti G; Fretz H; Schoepfer J; Gay B
J Mol Biol; 1998 Jun; 279(4):1013-22. PubMed ID: 9642078
[TBL] [Abstract][Full Text] [Related]
28. Dual specificity of Src homology 2 domains for phosphotyrosine peptide ligands.
Gay B; Furet P; García-Echeverría C; Rahuel J; Chène P; Fretz H; Schoepfer J; Caravatti G
Biochemistry; 1997 May; 36(19):5712-8. PubMed ID: 9153411
[TBL] [Abstract][Full Text] [Related]
29. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
[TBL] [Abstract][Full Text] [Related]
30. Structure-based design and synthesis of high affinity tripeptide ligands of the Grb2-SH2 domain.
Furet P; Gay B; Caravatti G; García-Echeverría C; Rahuel J; Schoepfer J; Fretz H
J Med Chem; 1998 Aug; 41(18):3442-9. PubMed ID: 9719597
[TBL] [Abstract][Full Text] [Related]
31. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
Eck MJ; Shoelson SE; Harrison SC
Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
[TBL] [Abstract][Full Text] [Related]
32. Identification of phosphopeptide ligands for the Src-homology 2 (SH2) domain of Grb2 by phage display.
Gram H; Schmitz R; Zuber JF; Baumann G
Eur J Biochem; 1997 Jun; 246(3):633-7. PubMed ID: 9219519
[TBL] [Abstract][Full Text] [Related]
33. Conformation of an Shc-derived phosphotyrosine-containing peptide complexed with the Grb2 SH2 domain.
Ogura K; Tsuchiya S; Terasawa H; Yuzawa S; Hatanaka H; Mandiyan V; Schlessinger J; Inagaki F
J Biomol NMR; 1997 Oct; 10(3):273-8. PubMed ID: 9390405
[TBL] [Abstract][Full Text] [Related]
34. Grb2 SH2 domain-binding peptide analogs as potential anticancer agents.
Lung FD; Tsai JY
Biopolymers; 2003; 71(2):132-40. PubMed ID: 12767115
[TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics.
Oishi S; Karki RG; Kang SU; Wang X; Worthy KM; Bindu LK; Nicklaus MC; Fisher RJ; Burke TR
J Med Chem; 2005 Feb; 48(3):764-72. PubMed ID: 15689160
[TBL] [Abstract][Full Text] [Related]
36. Inhibitors of Ras signal transduction as antitumor agents.
Garbay C; Liu WQ; Vidal M; Roques BP
Biochem Pharmacol; 2000 Oct; 60(8):1165-9. PubMed ID: 11007954
[TBL] [Abstract][Full Text] [Related]
37. N-terminal carboxyl and tetrazole-containing amides as adjuvants to Grb2 SH2 domain ligand binding.
Burke TR; Yao ZJ; Gao Y; Wu JX; Zhu X; Luo JH; Guo R; Yang D
Bioorg Med Chem; 2001 Jun; 9(6):1439-45. PubMed ID: 11408162
[TBL] [Abstract][Full Text] [Related]
38. Sam68 associates with the SH3 domains of Grb2 recruiting GAP to the Grb2-SOS complex in insulin receptor signaling.
Najib S; Sánchez-Margalet V
J Cell Biochem; 2002; 86(1):99-106. PubMed ID: 12112020
[TBL] [Abstract][Full Text] [Related]
39. Dynamin II associates with Grb2 SH3 domain in Ras transformed NIH3T3 cells.
Yoon SY; Koh WS; Lee MK; Park YM; Han MY
Biochem Biophys Res Commun; 1997 May; 234(3):539-43. PubMed ID: 9175747
[TBL] [Abstract][Full Text] [Related]
40. Surface plasmon resonance thermodynamic and kinetic analysis as a strategic tool in drug design. Distinct ways for phosphopeptides to plug into Src- and Grb2 SH2 domains.
de Mol NJ; Dekker FJ; Broutin I; Fischer MJ; Liskamp RM
J Med Chem; 2005 Feb; 48(3):753-63. PubMed ID: 15689159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
